Telomir Pharmaceuticals (TELO) Operating Expenses (2023 - 2026)
Telomir Pharmaceuticals (TELO) reported Operating Expenses of $1.76 million for Q2 2026, down 65.2% from $5.07 million a year earlier.
Powered by 
Analysis
Telomir Pharmaceuticals (TELO) Operating Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Telomir Pharmaceuticals' Operating Expenses came in at $10.12 million, down 37.4% year-over-year; for FY2025, it was $10.54 million, down 13.9% from FY2024.
- Operating Expenses has a three-year compound annual growth rate of 131.1% (FY2022 to FY2025).
- By year, Operating Expenses came in at $12.24 million in FY2024 (+210.6%), $3.94 million in FY2023 (+361.5%) and $854,147 in FY2022.
- Five-year quarterly Operating Expenses spans a low of $482,938 in Q1 2023 and a high of $6.01 million in Q3 2024.
- Year over year, Operating Expenses gained in four of the last seven quarters, with growth averaging 112.0%.
- The high point for year-over-year Operating Expenses in five years was Q3 2024 (growth of 529.5%); the low point was Q3 2025 (a decline of 80.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Telomir Pharmaceuticals | 82.53 Mn | 82.53 Mn | - | 1.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 5.07 Mn |
| Mar 31, 2025 | 2.19 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 954,153.00 |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 482,938.00 |
API Access
Telomir Pharmaceuticals Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=TELO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "TELO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=TELO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();